Human protein tyrosine phosphatase inhibitors and methods of use
US8338615B2 · kind B2 · utility
41Cited by
19References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2011 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Dec 1, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.